Back
Indaptus Therapeutics, Inc. 10K Form
Sell
25
INDP
Indaptus Therapeutics, Inc.
Last Price:
$2.06
Seasonality Move:
-11.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INDP News And Ratings
See the #1 stock for the next 7 days that we like better than INDP
INDP Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.81 |
| Price / Book: | 0.25 |
Profitability
| EPS (TTM): | -22.83350 |
|---|---|
| Net Income (TTM): | $-16.9M |
| Gross Margin: | $-700 |
| Return on Equity: | -537.86% |
| Return on Assets: | -243.26% |
Indaptus Therapeutics, Inc. Earnings Forecast
Key Indaptus Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 17 years have been positive in 8 years.
Indaptus Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INDP |
| Website: | indaptusrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.88 |
| Quick Ratio: | 2.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INDP Technical Analysis vs Fundamental Analysis
Sell
25
Indaptus Therapeutics, Inc. (INDP)
is a Sell
Is Indaptus Therapeutics, Inc. a Buy or a Sell?
-
Indaptus Therapeutics, Inc. stock is rated a SellThe current Indaptus Therapeutics, Inc. [INDP] share price is $2.03. The Score for INDP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.